Nusano plans to begin production of other medical isotopes, such as copper-67 and actinium-225, both of which are used in Clarity's products, in 2025-2026. Clarity's Executive Chairperson ...

nickel-64 (Ni-64), and plans to commence production of copper-67 (Cu-67 or 67 Cu) and actinium-225 (Ac-225 or 225 Ac) isotopes in 2025-2026. Both of these isotopes are used in Clarity's pipeline ...

nickel-64 (Ni-64), and plans to commence production of copper-67 (Cu-67 or 67Cu) and actinium-225 (Ac-225 or 225Ac) isotopes in 2025-2026. Both of these isotopes are used in Clarity's pipeline of ...

Nusano plans to begin production of other medical isotopes, such as copper-67 and actinium-225, both of which are used in Clarity's products, in 2025-2026.

nickel-64 (Ni-64), and plans to commence production of copper-67 (Cu-67 or 67 Cu) and actinium-225 (Ac-225 or 225 Ac) isotopes in 2025-2026. Both of these isotopes are used in Clarity's pipeline of ...

Chevrolet Corvette convertible in Goodwood Green has undergone a full restoration under prior ownership and it is absolutely ...

2-Year U.S. Treasury Note Continuous Contract $103.793 0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $108.414-0.063-0.06% 10-Year U.S. Treasury Note Continuous Contract $111.172-0.266 ...

Additionally, alternative beta emitters like Copper-67, Iodine-131, and Terbium-161 can diversify radioisotope sources and mitigate supply-side pressures. Establishing a robust supply chain for ...

What is the current share price of Clarity Pharmaceuticals Ltd (CU6)? Clarity Pharmaceuticals Ltd's (CU6) current share price is $1.90. This constitutes a price movement of 14.80% when compared to the ...

is pleased to announce the signing of a commercial-scale Supply Agreement for copper-64 with Nusano. As the Australian market navigates a period of slower trade and investor caution amid ongoing ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...